Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
NORTHERN TRUST CORP
> RVNC
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | Revance Therapeutics, Inc. | RVNC | 829,774 | 23,674 | 21,001,580,000 | -4,962,900,000 | $25,310.00 |
| 03/31/2023 | Revance Therapeutics, Inc. | RVNC | 806,100 | 90,451 | 25,964,480,000 | 25,945,157,000 | $32,210.00 |
| 09/30/2022 | Revance Therapeutics, Inc. | RVNC | 715,649 | 37,349 | 19,323,000 | 9,950,000 | $27.00 |
| 06/30/2022 | Revance Therapeutics, Inc. | RVNC | 678,300 | -28,316 | 9,373,000 | -4,405,000 | $13.82 |
| 03/31/2022 | Revance Therapeutics, Inc. | RVNC | 706,616 | -23,941 | 13,778,000 | 1,856,000 | $19.50 |
| 12/31/2021 | Revance Therapeutics, Inc. | RVNC | 730,557 | -7,525 | 11,922,000 | -8,640,000 | $16.32 |
| 09/30/2021 | Revance Therapeutics, Inc. | RVNC | 738,082 | -13,770 | 20,562,000 | -1,722,000 | $27.86 |
| 06/30/2021 | Revance Therapeutics, Inc. | RVNC | 751,852 | -11,772 | 22,284,000 | 642,000 | $29.64 |
| 12/31/2020 | Revance Therapeutics, Inc. | RVNC | 763,624 | -23,304 | 21,642,000 | 1,858,000 | $28.34 |
| 09/30/2020 | Revance Therapeutics, Inc. | RVNC | 786,928 | 125,536 | 19,784,000 | 9,996,000 | $25.14 |
| 03/31/2020 | Revance Therapeutics, Inc. | RVNC | 661,392 | 73,968 | 9,788,000 | 254,000 | $14.80 |
| 12/31/2019 | Revance Therapeutics, Inc. | RVNC | 587,424 | 24,494 | 9,534,000 | 2,216,000 | $16.23 |
| 09/30/2019 | Revance Therapeutics, Inc. | RVNC | 562,930 | 57,485 | 7,318,000 | 762,000 | $13.00 |
| 06/30/2019 | Revance Therapeutics, Inc. | RVNC | 505,445 | 6,511 | 6,556,000 | -1,308,000 | $12.97 |
| 03/31/2019 | Revance Therapeutics, Inc. | RVNC | 498,934 | 70,584 | 7,864,000 | -758,000 | $15.76 |
| 12/31/2018 | Revance Therapeutics, Inc. | RVNC | 428,350 | -10,519 | 8,622,000 | -2,284,000 | $20.13 |
| 09/30/2018 | Revance Therapeutics, Inc. | RVNC | 438,869 | 23,013 | 10,906,000 | -509,000 | $24.85 |
| 06/30/2018 | Revance Therapeutics, Inc. | RVNC | 415,856 | 76,406 | 11,415,000 | 960,000 | $27.45 |
| 03/31/2018 | Revance Therapeutics, Inc. | RVNC | 339,450 | 38,045 | 10,455,000 | -319,000 | $30.80 |
| 12/31/2017 | Revance Therapeutics, Inc. | RVNC | 301,405 | 10,455 | 10,774,000 | 2,759,000 | $35.75 |
| 09/30/2017 | Revance Therapeutics, Inc. | RVNC | 290,950 | -27,927 | 8,015,000 | -403,000 | $27.55 |
| 06/30/2017 | Revance Therapeutics, Inc. | RVNC | 318,877 | 52,940 | 8,418,000 | 2,886,000 | $26.40 |
| 03/31/2017 | Revance Therapeutics, Inc. | RVNC | 265,937 | 265,937 | 5,532,000 | 5,532,000 | $20.80 |
| << Prev Next >> |
|